Drug Pipeline

Aficamten Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
4
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-20 NCT07600177 Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic… Phase 4 Recruiting
Active Studies by Phase
Phase 4
1
Phase 3
2
Phase 2/3
2
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07600177 Mavacamten to Aficamten Transition in Patients With Obstructive Hypertrophic… Hypertrophic Cardiomyopathy (HCM) Recruiting
Phase 3
NCT06081894 Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in… Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy Active, Not Recruiting
NCT07023341 A Study to Learn More About How Well Aficamten Works in Japanese Participants With… Obstructive Hypertrophic Cardiomyopathy Active, Not Recruiting
Phase 2/3
NCT06412666 A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic… Pediatric Recruiting
NCT04848506 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten… Symptomatic Hypertrophic Cardiomyopathy (HCM) Enrolling by Invitation
Sponsors Running Aficamten Trials
Get alerts when Aficamten trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free